Caliber Imaging & Diagnostics, Inc. announced that it has received $2.786032 million in funding

Caliber Imaging & Diagnostics, Inc. is a medical technology company. The Company designs, develops, and markets imaging solutions that show tissue at the cellular level. It offers in-vivo confocal microscopes designed specifically for imaging skin and other tissue. Its Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye. It has developed the VivaScope, a suite of imaging products. Its telepathology system allows near real-time collaboration with remote specialists. Its clinical products include VivaScope 1500, VivaScope 2500, VivaScope 3000 and VivaNet & VivaScan. Its research products include RS-G4 Upright, RS-G4 Inverted, Specialty Confocal Microscopes and Research Software Suite. The VivaScope 1500 reflectance confocal imaging system offers a non-invasive way to image the skin in vivo from the surface to the superficial collagen layers.